Evaluation of erectile dysfunction with color Doppler sonography by Bari, Vaqar et al.
eCommons@AKU
Department of Radiology Medical College, Pakistan
June 2006
Evaluation of erectile dysfunction with color
Doppler sonography
Vaqar Bari
Aga Khan University, vaqar.bari@aku.edu
M Nadeem Ahmed
Aga Khan University, nadeem.ahmed@aku.edu
M Zafar Rafique
Kashif Ashraf
Aga Khan University, kashif.ashraf@aku.edu
Waseem Ahmad Memon
See next page for additional authors
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol
Part of the Radiology Commons
Recommended Citation
Bari, V., Ahmed, M. N., Rafique, M. Z., Ashraf, K., Memon, W. A., Usman, M. U. (2006). Evaluation of erectile dysfunction with color
Doppler sonography. Journal of Pakistan Medical Association, 56(6), 258-261.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol/190
Authors
Vaqar Bari, M Nadeem Ahmed, M Zafar Rafique, Kashif Ashraf, Waseem Ahmad Memon, and M Uzair
Usman
This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_radiol/190
258 J Pak Med Assoc
Original Article
Evaluation of Erectile Dysfunction with Color Doppler Sonography
Vaqar Bari, M. Nadeem Ahmed, M. Zafar Rafique, Kashif Ashraf, Waseem Ahmad Memon,  M. Uzair Usman
Radiology Department, Aga Khan University Hospital, Karachi
Abstract
Objective: To assess the role of Color Doppler Sonography in the evaluation of erectile dysfunction.
Methods: A cross-sectional study was conducted at the Radiology Department, Aga Khan University Hospital
Karachi from 5-6-2002 to 2-9-2003. All consecutive patients presenting with erectile dysfunction and undergoing
penile color Doppler evaluation with injection PGE1 20 mcg were included in this study. 
Results: A total of 70 patients with an age range of 24-70 years {mean 41+ 12.25 years} were included in the
study. A normal response was noted in 45 (psychogenic) cases. Vasculogenic causes were observed in 23
patients, 12 with arterial insufficiency and 11 with venous leak. Peyronie's disease was diagnosed in 2 patients.
Conclusion: Color Doppler evaluation of erectile dysfunction is an effective method for differentiating psy-
chogenic and vasculogenic causes of erectile dysfunction (JPMA 56:258;2006). 
Introduction
Color Doppler sonography can be useful in the eval-
uation of erectile dysfunction, which can result from psy-
chogenic, endocrinologic, neurogenic, pharmacologic, and
vasogenic causes. It is used to determine the integrity of the
vascular mechanism.
The National Institutes of Health (NIH) Consensus
Development Conference1 advocated that "erectile dysfunc-
tion" be used instead of "impotence" to describe disorders of
male sexual function and defined the new terminology as
the "inability to achieve an erect penis as part of the overall
multifaceted process of male sexual function." However,
use of the term "erectile dysfunction" to refer to all aspects
of male sexual dysfunction would be inappropriate.
Although the exact prevalence of erectile dysfunc-
tion in the United States male population is not known, esti-
mates have ranged from 12% of males above age 18 in the
report of Furlow2 to 25-30% of men between ages 60 and 70
in the surveys of Kinsey and colleagues2, Schiavi and col-
leagues3 and Diokno and colleagues4 and 52% in the
Massachusetts Male Aging Study.5 Disorders of sexual
function are common among men of all ages, ethnicities and
cultural backgrounds. It has been estimated that more than
152 million men worldwide experienced erectile dysfunc-
tion in 1995, and that this number will rise by 170 million,
to approximately 322 million by the year 2025.6
The objective of this study was to assess the role of
color Doppler sonography in the evaluation of erectile dys-
function.
Patients and Methods
The study was conducted at the Radiology
Department, Aga Khan University Hospital Karachi from
5-6-2002 to 2-9-2003. A total of 70 consecutive patients
presenting with erectile dysfunction and undergoing penile
color Doppler evaluation with injection Prostaglandin E1
20mcg were included in this study. 
A grey scale ultrasound was performed in both lon-
gitudinal as well as transverse sections to see any plaque or
abnormality. This was followed by a baseline study of the
cavernosal arteries and pre-injection velocities were record-
ed. A brief history was taken and adequate privacy and quiet
surrounding was provided to allay patient anxiety as much
as possible. The study was performed by one of three expe-
rienced radiologists. All studies were performed on GE
Logiq 500 and Aloka Prosound SSD 4000 Doppler
machines with high frequency transducer and duplex and
color Doppler facility. Sampling factors, accurate gate
placement and angle correction was optimized for consis-
tent and reproducible results. Spectral waveforms from the
cavernosal artery were measured at the base of penis as
velocities are highest here and angle correction is optimal.
Intracavernosal injection of 20 microgram of
prostaglandin E1 with a 28 G needle close to the base of
penis was given and massaged in. Measurements of peak
systolic and end-diastolic velocities were obtained in each
cavernosal artery at 5-min intervals for a total of 30 minutes.
A peak systolic velocity of less than 25 cm/sec was used as
the threshold for arterial insufficiency. An end-diastolic
velocity of greater than 5 cm/sec was used to predict venous
incompetence. The images were recorded and printed on
paper. Erection was graded at 10 minutes as follows: 1- no
erection; 2- slight tumescence; 3- full volume without rigid-
ity; 4- incomplete rigidity but sufficient for sexual 
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intercourse; 5- full erection with unbending rigidity.
Results
Seventy patients with an age range of 24-70 years
(mean 41 + 12.25 years) were included in the study. A vast
majority was in the 30-40 years age group (42%). Two
patients had primary erectile dysfunction and sixty eight
had developed this problem after a period of normal sexual
activity. Both patients with primary erectile dysfunction had
arterial insufficiency on Doppler study. The duration of
symptoms varied from 2 months to 3 years in cases of
acquired erectile dysfunction. Four patients had diabetes
mellitus and all of them had arterial insufficiency.
A normal response was noted in 45 subjects (64%)
and their problem was considered to be psychogenic. Most
of them achieved a peak systolic velocity of 50 cms/ sec and
had either reversal of flow in diastole or an end diastolic
velocity less than 5cms/sec. The highest peak systolic
velocity achieved was 105 cms/sec. Detumescence was
noted in all these cases in about 20-35 minutes. No priapism
case was encountered in this study.
Vasculogenic causes were noted in 23 patients
(33%), 12 with arterial insufficiency and 11 with venous
leak. The lowest peak systolic velocity in arterial insuffi-
ciency patients was 10-13 cms/sec and highest velocity
achieved was 22cms/sec. In patients with venous leak, the
end diastolic velocity was above 6cms/sec and highest
velocity recorded was 16-17 cms/sec. No patient in the vas-
culogenic group achieved a satisfactory erection. 
Peyronie's disease was diagnosed in 2 patients (3%)
with plaques in tunica albuginea and one of them had a
characteristic development of curvature with discomfort
during the Doppler evaluation. The other patient did not
develop curvature during the study. These two patients had
some delayed response to the injection but did not reveal
arterial insufficiency or venous leak.
Discussion
The normal male sexual response cycle can be func-
tionally divided into five interrelated events that occur in a
defined sequence: libido, erection, ejaculation, orgasm, and
detumescence. The functional classification of the male sex-
ual cycle is the most physically quantifiable one.
In 1982 during a vascular reconstructive procedure,
Ronald Virag noted that infusion of papaverine into the
hypogastric artery produced erection. In 1983 a dramatic
demonstration of the efficacy of penile self injection was
offered by Charles Brindley, who injected himself.7 In 1985
Lue et al introduced the technique of high resolution sonog-
raphy and quantitative Doppler spectrum analysis.8 In 1986
Ishii published the first clinical series on prostaglandin
E1 for self injection.9 Prostaglandin E1 because of its effica-
cy and safety (low priapism rates) is the drug of choice for
first penile injection. The demonstration that vasoactive
injections could produce penile erection without benefit of
psychic or tactile stimuli revolutionized the diagnosis and
treatment of erectile dysfunction by providing a direct test
of end organ integrity and offering an etiology specific ther-
apy.
In contrast to pudendal arteriography, duplex sonog-
raphy is not invasive and can be performed in the office set-
ting. The high resolution ultrasound probe allows the sono-
grapher to image the individual cavernous arteries selective-
ly and perform Doppler blood flow analysis simultaneously.
A fall of resistance within the corporeal vascular bed and
the subsequent increase in arterial inflow are the major vas-
cular events leading to erection of the penis.10 A dramatic
increase in penile arterial blood flow to about 25 to 60 times
that of the flaccid state occurs during the rapid period of
tumescence. Pulse Doppler analysis studies with intracav-
ernous vasoactive drug injections have established that a
peak cavernosal artery systolic flow greater than 25 ml/sec
is required for erection to occur.11 At full rigidity, an
increase in penile length of 7.5 cm usually requires the
entrapment of 80-115 ml of blood. As the penile volume
increases to near maximum (from <10 ml in the flaccid state
to  60 ml in the erect state), the arterial influx declines and
plateaus at a level that is sufficient to keep the penis in the
rigid (full erection) state. Dynamic infusion cavernosometry
and cavernosography (DICC) studies have shown that a
fluid flow rate between 5 and 40 ml/min is required to main-
tain a normal penis in the erect state.12 A peak systolic
velocity of at least 35 cm/sec indicates normal arterial sup-
ply. At peak systolic velocities less than 35 cm/sec, the like-
lihood and severity of arterial disease increase as the peak
systolic velocity decreases, with a peak velocity less than 25
cm/sec indicating a high likelihood of severe arterial dis-
ease.13
Vascular insufficiency is probably the most common
cause of organic male sexual dysfunction.14 Erectile dys-
function(ED) secondary to excessive venous leakage is
being reported with significant frequency in clinical stud-
ies.15 Penile diseases, such as congenital malformation,
Peyronie's disease, priapism and phimosis may interfere
with erectile function. Vasculogenic ED patients have more
markedly impaired endothelial and smooth muscle func-
tions compared with patients having similar risk factors but
no ED.16 The prevalence of co morbidities, such as vascular
conditions, increased with ED severity, which may indicate
that ED is a prognostic marker of overall health and an
important medical condition.17
PGE-1 (alprostadil) is a metabolite of arachidonic
acid and is a potent smooth muscle relaxant and
vasodilator in man. It also has an α-2 adrenergic blocking
effect and hence has the potential of reducing sympathetic
overtone in patients with psychogenic erectile dysfunction.
The overall erectile response to prostaglandin intracorpore-
al injections is about 70%.18 Pain is the most common side
effect, occurring in 13-80% of patients and is dose-related.
Other side effects associated with PGE-1 injections include
local corporeal haematoma or ecchymosis (8%), prolonged
erection to between 4 and 6 hours (5%), priapism of greater
than 6 h (1%), penile oedema (2%), and fibrosis (2.3%).19
About 40% of patients with impotence have evi-
dence of abnormal arterial flow. Generally, these conditions
are amenable to surgical correction, and about 60% of these
patients recover spontaneous erectile function postopera-
tively. The NIH Consensus Development Conference on
Impotence, held in 1992, recommended that surgical revas-
cularization of the penis be considered experimental and be
performed only by expert surgeons and as part of clinical
investigation.
Venous ligation results in initial recovery of erectile
function within the first 6 months of the surgery as reported
in 60% to 70% of patients.20 However, the long-term suc-
cess rate of penile vein ligation is poor, with only about 20%
of patients able to have normal intercourse more than 1 year
after surgery.21
Erectile function is an important question in lawsuits
for divorce, rape, and damages. Lawyers may abuse the
assertion of ED in lawsuits for divorce and rape. Doppler
evaluation is of considerable help in such cases. The inves-
tigation, interpretation, and characteristics of medicolegal
cases may differ in countries with different cultures. The
availability of effective and well-tolerated oral medications
has dramatically changed the clinical approach to erectile
dysfunction. Pharmacotherapy is the preferred cost-effec-
tive first-line therapy in the vast majority of patients.22
A new noninvasive method for penile Doppler ultra-
sound (PDU) evaluation of erectile dysfunction using oral
sildenafil citrate (Viagra) as an erection induction agent has
been used. The results of PDU with oral sildenafil citrate
were not statistically different from prostaglandin E1.
Patients commented that although PGE 1 was the strongest
erectogenic agent, sildenafil citrate was the most conven-
ient.23 Vardenafil is another safer alternative compared to
more invasive intracavernous injection and is also an alter-
native for patients who fear injections.24
Treatment of structural penile diseases depends upon
the nature of the underlying disease. Peyronie's disease can
be self-limiting in many cases and may not require thera-
peutic intervention. Medical treatment is suitable in the
acute phase (<12 months) of the disease when the plaque is
unstable. Oral therapeutic agents include vitamin E,
p-aminobenzoate. Other forms of medical therapy may
include local or systemic glucocorticoids and the intrale-
sional injection of a collagenase or a calcium channel block-
er (e.g., Verapamil). Medical therapy may help patients with
moderate disease, whereas surgical correction is the treat-
ment of choice for those with severe penile deformity.
Color Doppler evaluation of erectile dysfunction is
an effective method for differentiating psychogenic and vas-
culogenic causes of erectile dysfunction. As the choices for
therapy increase and become more etiology specific clini-
cians may look to testing like color Doppler ultrasound to
develop vascular profiles to help predict treatment success
with one or a combination of several agents.
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